HAE R&D to Revenue
Haemonetics Corp · R&D to Revenue
HAE R&D to Revenue
Latest reported4.77%period ending
HAE Quarterly R&D/Revenue (0.00% → 4.77%)
Latest values, visible window
High-resolution chart · PNG
HAE r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4.7734% | |
| 4.1709% | |
| 4.2149% | |
| 4.437% | |
| 5.0595% | |
| 4.8273% | |
| 4.5415% | |
| 4.0922% | |
| 4.2981% | |
| 7.1243% | |
| 3.945% | |
| 3.9804% | |
| 4.0625% | |
| 7.9313% | |
| 4.1562% | |
| 3.6627% | |
| 4.1697% | |
| 8.1547% | |
| 3.8638% | |
| 4.524% | |
| 5.5577% | |
| 8.2847% | |
| 3.1206% | |
| 3.2284% | |
| 3.9626% | |
| 7.2011% | |
| 2.703% | |
| 2.9386% | |
| 3.1398% | |
| 3.5087% | |
| 3.6296% | |
| 3.5528% | |
| 4.1012% | |
| 4.7471% | |
| 5.3097% | |
| 3.3371% | |
| 3.8838% | |
| 8.3401% | |
| 3.714% | |
| 3.7847% | |
| 5.4473% | |
| 9.0983% | |
| 4.6884% | |
| 5.2587% | |
| 5.3047% | |
| 7.6056% | |
| 4.5909% | |
| 4.8062% | |
| 6.852% | |
| 5.7389% | |
| 5.8686% | |
| 6.3396% | |
| 5.1056% | |
| 7.1289% | |
| 4.2798% | |
| 4.9625% | |
| 5.3316% | |
| 4.613% | |
| 4.8295% | |
| 5.7678% | |
| 5.0472% | |
| 5.1672% | |
| 4.5229% | |
| 4.7676% | |
| 4.8577% | |
| 3.9396% | |
| 3.9118% | |
| 4.1224% | |
| 4.3982% | |
| 4.5657% | |
| 3.7569% | |
| 3.5753% | |
| 4.0551% | |
| 4.1733% | |
| 4.1081% | |
| 5.5513% | |
| 5.147% | |
| 5.5928% | |
| 5.1124% | |
| 5.6403% | |
| 4.8991% | |
| 4.7366% | |
| 8.9546% | |
| 6.2525% | |
| 5.3706% | |
| 5.1043% | |
| 6.7117% | |
| 4.6776% | |
| 4.2853% | |
| 4.1977% | |
| 4.4877% | |
| 5.283% | |
| 5.6602% | |
| 5.9717% | |
| 5.3183% | |
| 5.8719% | |
| 6.0279% | |
| -6.8764% | |
| 17.9432% | |
| 6.1806% |